658 related articles for article (PubMed ID: 23331565)
1. House dust mite sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with allergic rhinitis.
Bozek A; Ignasiak B; Filipowska B; Jarzab J
Clin Exp Allergy; 2013 Feb; 43(2):242-8. PubMed ID: 23331565
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis.
Okubo K; Masuyama K; Imai T; Okamiya K; Stage BS; Seitzberg D; Konno A
J Allergy Clin Immunol; 2017 Jun; 139(6):1840-1848.e10. PubMed ID: 27864024
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.
Virchow JC; Backer V; Kuna P; Prieto L; Nolte H; Villesen HH; Ljørring C; Riis B; de Blay F
JAMA; 2016 Apr; 315(16):1715-25. PubMed ID: 27115376
[TBL] [Abstract][Full Text] [Related]
4. Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial.
Demoly P; Emminger W; Rehm D; Backer V; Tommerup L; Kleine-Tebbe J
J Allergy Clin Immunol; 2016 Feb; 137(2):444-451.e8. PubMed ID: 26292778
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial.
Nolte H; Bernstein DI; Nelson HS; Kleine-Tebbe J; Sussman GL; Seitzberg D; Rehm D; Kaur A; Li Z; Lu S
J Allergy Clin Immunol; 2016 Dec; 138(6):1631-1638. PubMed ID: 27521719
[TBL] [Abstract][Full Text] [Related]
6. Allergen-specific immunotherapy for allergic rhinitis in the elderly: is it never too late?
Milani M
Immunotherapy; 2013 Jul; 5(7):699-702. PubMed ID: 23829621
[TBL] [Abstract][Full Text] [Related]
7. The SQ House Dust Mite SLIT-Tablet Is Well Tolerated in Patients with House Dust Mite Respiratory Allergic Disease.
Emminger W; Hernández MD; Cardona V; Smeenk F; Fogh BS; Calderon MA; de Blay F; Backer V
Int Arch Allergy Immunol; 2017; 174(1):35-44. PubMed ID: 28950268
[TBL] [Abstract][Full Text] [Related]
8. House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study.
Guez S; Vatrinet C; Fadel R; André C
Allergy; 2000 Apr; 55(4):369-75. PubMed ID: 10782522
[TBL] [Abstract][Full Text] [Related]
9. Sublingual house dust mite immunotherapy has no impact on decrease of circulating erythrocytes upon airway allergen challenge in allergic rhinitis.
Jordakieva G; Kundi M; Lemell P; Zieglmayer R; Zieglmayer P; Godnic-Cvar J; Jensen-Jarolim E
Sci Rep; 2017 May; 7(1):2555. PubMed ID: 28566688
[TBL] [Abstract][Full Text] [Related]
10. Changes in serum specific IgG4 and IgG4/ IgE ratio in mite-sensitized Taiwanese children with allergic rhinitis receiving short-term sublingual-swallow immunotherapy: a multicenter, randomized, placebo-controlled trial.
Tseng SH; Fu LS; Nong BR; Weng JD; Shyur SD
Asian Pac J Allergy Immunol; 2008; 26(2-3):105-12. PubMed ID: 19054928
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double-blind, randomized, placebo-controlled trial.
Varney VA; Tabbah K; Mavroleon G; Frew AJ
Clin Exp Allergy; 2003 Aug; 33(8):1076-82. PubMed ID: 12911781
[TBL] [Abstract][Full Text] [Related]
12. Prolonged effect of allergen sublingual immunotherapy for house dust mites in elderly patients.
Bozek A; Starczewska-Dymek L; Jarzab J
Ann Allergy Asthma Immunol; 2017 Jul; 119(1):77-82. PubMed ID: 28668244
[TBL] [Abstract][Full Text] [Related]
13. SQ house dust mite (HDM) SLIT-tablet provides clinical improvement in HDM-induced allergic rhinitis.
Klimek L; Mosbech H; Zieglmayer P; Rehm D; Stage BS; Demoly P
Expert Rev Clin Immunol; 2016; 12(4):369-77. PubMed ID: 26788764
[TBL] [Abstract][Full Text] [Related]
14. A 300 IR sublingual tablet is an effective, safe treatment for house dust mite-induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial.
Demoly P; Corren J; Creticos P; De Blay F; Gevaert P; Hellings P; Kowal K; Le Gall M; Nenasheva N; Passalacqua G; Pfaar O; Tortajada-Girbés M; Vidal C; Worm M; Casale TB
J Allergy Clin Immunol; 2021 Mar; 147(3):1020-1030.e10. PubMed ID: 32890575
[TBL] [Abstract][Full Text] [Related]
15. Two year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing subcutaneous and sublingual immunotherapy.
Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
Asian Pac J Allergy Immunol; 2013 Sep; 31(3):233-41. PubMed ID: 24053706
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo controlled trial of sublingual immunotherapy with house-dust mite extract for allergic rhinitis.
Guo Y; Li Y; Wang D; Liu Q; Liu Z; Hu L
Am J Rhinol Allergy; 2017 Jul; 31(4):42-47. PubMed ID: 28716168
[TBL] [Abstract][Full Text] [Related]
17. [The efficacy of sublingual specific immunotherapy in children with allergic rhinitis].
Li P; Fa M; Huang ZH; Xie LS; Xu Y; Chen WB; Zhang JY; Zhang XR; Zhu Z; Li Q
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 30(7):546-551. PubMed ID: 29871066
[No Abstract] [Full Text] [Related]
18. Pooled efficacy and safety data for house dust mite sublingual immunotherapy tablets in adolescents.
Matsuoka T; Bernstein DI; Masuyama K; Nolte H; Okamiya K; Seitzberg D; Nelson HS
Pediatr Allergy Immunol; 2017 Nov; 28(7):661-667. PubMed ID: 28660739
[TBL] [Abstract][Full Text] [Related]
19. New Suggestions in Sublingual Immunotherapy for House Dust Mite- Related Allergic Diseases.
Ferrando M; Bagnasco D; Passa-Lacqua G; Puggioni F; Varricchi G; Canonica GW
Curr Pharm Biotechnol; 2017; 18(5):378-383. PubMed ID: 28413977
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of sublingual immunotherapy for house dust mite allergic rhinitis.
Cingi C; Bayar Muluk N; Ulusoy S; Acar M; Şirin S; Çobanoğlu B; Birdane L; Kalaycık Ç; Çakır BÖ; Oğhan F; Aynacı S; Erdoğmuş N; Yıldırım Ö; Şahin E; Bulut F; Aksoy MA; Türe N; Bal C
Eur Arch Otorhinolaryngol; 2015 Nov; 272(11):3341-6. PubMed ID: 25516223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
